Mostrar el registro sencillo del ítem

Autordc.contributor.authorRodríguez Arce, Esteban 
Autordc.contributor.authorCancino Rivera, Patricio 
Autordc.contributor.authorArias Calderón, Manuel 
Autordc.contributor.authorSilva Matus, Paul 
Autordc.contributor.authorSaldías, Marianela 
Fecha ingresodc.date.accessioned2020-05-08T14:21:12Z
Fecha disponibledc.date.available2020-05-08T14:21:12Z
Fecha de publicacióndc.date.issued2020
Cita de ítemdc.identifier.citationMolecules 2020, 25, 108es_ES
Identificadordc.identifier.other10.3390/molecules25010108
Identificadordc.identifier.urihttps://repositorio.uchile.cl/handle/2250/174583
Resumendc.description.abstractCancer is a disease that involves impaired genome stability with a high mortality index globally. Since its discovery, many have searched for effective treatment, assessing different molecules for their anticancer activity. One of the most studied sources for anticancer therapy is natural compounds and their derivates, like alkaloids, which are organic molecules containing nitrogen atoms in their structure. Among them, oxoisoaporphine and sampangine compounds are receiving increased attention due to their potential anticancer effects. Boldine has also been tested as an anticancer molecule. Boldine is the primary alkaloid extract from boldo, an endemic tree in Chile. These compounds and their derivatives have unique structural properties that potentially have an anticancer mechanism. Different studies showed that this molecule can target cancer cells through several mechanisms, including reactive oxygen species generation, DNA binding, and telomerase enzyme inhibition. In this review, we summarize the state-of-art research related to oxoisoaporphine, sampangine, and boldine, with emphasis on their structural characteristics and the relationship between structure, activity, methods of extraction or synthesis, and anticancer mechanism. With an effective cancer therapy still lacking, these three compounds are good candidates for new anticancer research.es_ES
Patrocinadordc.description.sponsorshipCONICT+PAI/Convocatoria Nacional Subvención a la Instalación en la Academia (SIA), Convocatoria 2018 77180052es_ES
Idiomadc.language.isoenes_ES
Publicadordc.publisherMDPIes_ES
Tipo de licenciadc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link a Licenciadc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Fuentedc.sourceMoleculeses_ES
Palabras clavesdc.subjectTelomerase inhibitiones_ES
Palabras clavesdc.subjectAlkaloidses_ES
Palabras clavesdc.subjectOxoisoaporphinees_ES
Palabras clavesdc.subjectAporphinees_ES
Palabras clavesdc.subjectBoldinees_ES
Palabras clavesdc.subjectROSes_ES
Palabras clavesdc.subjectAnticancer actiones_ES
Palabras clavesdc.subjectSampanginees_ES
Palabras clavesdc.subjectStructure–biological activityes_ES
Títulodc.titleOxoisoaporphines and aporphines: Versatile molecules with anticancer Efectses_ES
Tipo de documentodc.typeArtículo de revistaes_ES
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogadoruchile.catalogadorctces_ES
Indizaciónuchile.indexArtículo de publicación ISI
Indizaciónuchile.indexArtículo de publicación SCOPUS


Descargar archivo

Icon

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivs 3.0 Chile
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivs 3.0 Chile